Zoetis Receives FDA Approval for Convenia® RTU for Dogs , Helping More Medium and Large Dogs Access Single-Injection Treatment
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1
Zoetis Receives Emergency Use Authorization for Simparica Trio® for Treatment of New World Screwworm Infestations in Dogs and Puppies
Zoetis Releases 2025 Sustainability Report: Advancing Sustainability in Animal Health for a Better Future
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
